Segregation analysis showed that in approximately half of these families the variants did not completely co-segregate with disease, suggesting that PALB2 acts as a medium-penetrance rather than high-penetrance gene for breast cancer risk [6]. The gene discussed is PALB2; the disease is breast carcinoma.